Structures by: Cleetus A.
Total: 7
C8H4FNO2
C8H4FNO2
CrystEngComm (2020) 22, 15 2566-2572
a=4.8425(7)Å b=24.450(4)Å c=5.7818(9)Å
α=90° β=99.096(5)° γ=90°
C10H10FNO3S
C10H10FNO3S
CrystEngComm (2020) 22, 15 2566-2572
a=8.2627(6)Å b=8.3350(6)Å c=8.7473(6)Å
α=91.177(2)° β=117.067(2)° γ=97.410(3)°
C14H9FN2O4
C14H9FN2O4
CrystEngComm (2020) 22, 15 2566-2572
a=12.8358(7)Å b=6.1720(3)Å c=15.5627(8)Å
α=90° β=96.692(2)° γ=90°
C8H4FNO2
C8H4FNO2
CrystEngComm (2020) 22, 15 2566-2572
a=3.7104(4)Å b=12.1407(15)Å c=14.7660(15)Å
α=90° β=93.397(4)° γ=90°
Methyl 4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C13H13FN2O3
Acta Crystallographica Section C (2020) 76, 8
a=16.0881(15)Å b=7.1958(8)Å c=23.177(3)Å
α=90° β=108.838(4)° γ=90°
Methyl 4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate ethyl acetate hemisolvate
C13H13FN2O3,0.5(C4H8O2)
Acta Crystallographica Section C (2020) 76, 8
a=7.3353(2)Å b=8.9091(2)Å c=12.5006(4)Å
α=82.389(2)° β=79.380(2)° γ=65.898(2)°
Methyl 4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate carbon tetrachloride 0.25-solvate
4(C13H13FN2O3),C1Cl4
Acta Crystallographica Section C (2020) 76, 8
a=16.2070(7)Å b=9.1642(4)Å c=17.9630(7)Å
α=90° β=91.607(2)° γ=90°